In Vitro and In Vivo Efficacy of CD38 Directed Therapy with Daratumumab In the Treatment of Multiple Myeloma

被引：0
|
作者：
Groen, Richard W. [1 ]
van der Veer, Michael [1 ]
Hofhuis, Frans M. [1 ]
van Kessel, Berris [1 ]
de Weers, Michel [2 ]
Parren, Paul W. H. I. [2 ]
Lokhorst, Henk M. [1 ]
Mutis, Tuna [1 ]
Martens, Anton [1 ]
机构：
[1] UMC Utrecht, Utrecht, Netherlands
[2] Genmab BV, Utrecht, Netherlands
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1261 / 1262
页数：2
相关论文
共 50 条
  • [41] Evaluating Daratumumab in the Treatment of Multiple Myeloma: Safety, Efficacy and Place in Therapy
    Dima, Danai
    Dower, Joshua
    Comenzo, Raymond L.
    Varga, Cindy
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 7891 - 7903
  • [42] Crystal structure of CD38 in complex with daratumumab, a first-in-class anti-CD38 antibody drug for treating multiple myeloma
    Lee, Hyun Tae
    Kim, Yujin
    Park, Ui Beom
    Jeong, Tae Jun
    Lee, Sang Hyung
    Heo, Yong-Seok
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 536 : 26 - 31
  • [43] DaratumumabNegative CD38 multiple myeloma: case report
    Reactions Weekly, 2019, 1749 (1) : 159 - 159
  • [44] CD38 antibodies in multiple myeloma: back to the future
    van de Donk, Niels W. C. J.
    Richardson, Paul G.
    Malavasi, Fabio
    BLOOD, 2018, 131 (01) : 13 - 29
  • [45] Registering a CD38 antibody upfront for multiple myeloma
    Hofmeister, Craig C.
    Nooka, Ajay
    Kaufman, Jonathan L.
    Lonial, Sagar
    LANCET, 2019, 394 (10192): : 3 - 4
  • [46] CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma
    Morandi, Fabio
    Horenstein, Alberto L.
    Costa, Federica
    Giuliani, Nicola
    Pistoia, Vito
    Malavasi, Fabio
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [47] Molecular dynamics of targeting CD38 in multiple myeloma
    Malavasi, Fabio
    Faini, Angelo C.
    Morandi, Fabio
    Castella, Barbara
    Incarnato, Danny
    Oliviero, Salvatore
    Horenstein, Alberto L.
    Massaia, Massimo
    van de Donk, Niels W. C. J.
    Richardson, Paul G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (03) : 581 - 591
  • [48] CD38 Monoclonal Antibody Therapies for Multiple Myeloma
    Wong, Sandy W.
    Comenzo, Raymond L.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (11): : 635 - 645
  • [49] The Role of CD38 in Multiple Myeloma Cell Biology
    Kawano, Yawara
    Kushima, Saki
    Hata, Hiroyuki
    Matsuoka, Masao
    BLOOD, 2021, 138
  • [50] VS38 Identifies Myeloma Cells With Dim CD38 Expression and Plasma Cells Following Daratumumab Therapy, Which Interferes With CD38 Detection for 4 to 6 Months
    Courville, Elizabeth L.
    Yohe, Sophia
    Shivers, Paula
    Linden, Michael A.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 153 (02) : 221 - 228
12345